Quantum Cyber director granted 190,840 options

O'Rourke Peter reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 08/04/2026 - 08:42 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

O'Rourke Peter reported acquisition or exercise transactions in this Form 4 filing.

Quantum Cyber N.V. director O'Rourke Peter received a grant of 190,840 stock options on 2026-07-31, each exercisable at 1.1400 per share into Ordinary Shares and expiring on 2036-08-03. The options vest in eighteen substantially equal monthly installments while he continues providing services, and this grant brings his reported derivative holdings to 190,840 options.

Insider Trade Summary

Grant/Award: 190,840 shares

Grant/Award 1 txn

Insider O'Rourke Peter

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	190,840	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 190,840 contracts (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 190,840 contracts (Direct)

Footnotes (1)

1. F1. The Stock Options will vest in eighteen substantially equal installments on each monthly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.

Key Figures

Stock options granted: 190,840 options Exercise price: 1.1400 per share Underlying Ordinary Shares: 190,840 shares +2 more

5 metrics

Stock options granted 190,840 options Grant to director O'Rourke Peter on 2026-07-31

Exercise price 1.1400 per share Exercise price for the granted stock options

Underlying Ordinary Shares 190,840 shares Shares issuable upon exercise of the granted options

Vesting installments 18 installments Options vest in eighteen substantially equal monthly installments

Option expiration date 2036-08-03 Expiration date of the granted stock options

Key Terms

Stock Option (Right to Buy), exercise price, vesting, Ordinary Shares

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy) granted to the director"

exercise price financial

"conversion_or_exercise_price 1.1400 represents the exercise price per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The Stock Options will vest in eighteen substantially equal installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Ordinary Shares financial

"underlying_security_title: Ordinary Shares issuable upon exercise of options"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Quantum Cyber N.V. (QUCY) report for O'Rourke Peter?

Quantum Cyber N.V. reported that director O'Rourke Peter received 190,840 stock options on 2026-07-31. These options are a compensation-related grant, not an open-market purchase, and give him the right to acquire Ordinary Shares at a fixed exercise price.

How many Quantum Cyber (QUCY) shares are covered by O'Rourke Peter’s new options?

The option grant covers 190,840 underlying Ordinary Shares of Quantum Cyber N.V. Each option represents the right to buy one Ordinary Share, meaning the full grant aligns with 190,840 potential shares if all options are eventually exercised.

What is the exercise price and expiration date of the new QUCY stock options?

The options have an exercise price of 1.1400 per share and expire on 2036-08-03. This sets the price at which O'Rourke Peter can acquire Ordinary Shares, provided the options vest and remain outstanding until exercise.

How do the Quantum Cyber (QUCY) options granted to O'Rourke Peter vest?

The stock options will vest in eighteen substantially equal monthly installments starting from the grant date. Vesting continues only while O'Rourke Peter is providing services to Quantum Cyber N.V., so unvested portions depend on his ongoing service.

Were the new QUCY option grants to O'Rourke Peter made under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not selected, so this grant is not reported as being made under a pre-arranged Rule 10b5-1 trading plan. It is disclosed as a compensation-related award of stock options.

What is O'Rourke Peter’s reported derivative holdings in QUCY after this grant?

After the transaction, O'Rourke Peter is reported as directly holding 190,840 stock options. This total corresponds to the full amount of options granted in this filing and reflects his derivative position reported as of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Rourke Peter

(Last) (First) (Middle)

SUITE 400, 200 CONNECTICUT AVE

(Street)

NORWALK CONNECTICUT 06854

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Quantum Cyber N.V. [ QUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.14	07/31/2026		A		190,840		(1)	08/03/2036	Ordinary Shares	190,840	$0	190,840	D

Explanation of Responses:

1. The Stock Options will vest in eighteen substantially equal installments on each monthly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.

	/s/ Peter O'Rourke	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)